Towards a survival risk prediction model for metastatic NSCLC patients on durvalumab using whole-lung CT radiomics
BackgroundExisting criteria for predicting patient survival from immunotherapy are primarily centered on the PD-L1 status of patients. We tested the hypothesis that noninvasively captured baseline whole-lung radiomics features from CT images, baseline …